Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pharmerica Corporation

Pharmerica Corporation (PMC) Stock Overview

Explore Pharmerica Corporation’s financial performance, market position, analyst ratings, and future outlook.

PMC●NYSE
HealthcareMedical - Equipment & Services
$29.25
$0.00(0.00%)
U.S. Market opens in 49h 50m

Pharmerica Corporation (PMC)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio41.79
EPS (TTM)$0.61
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

PMC Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Pharmerica Corporation (NYSE: PMC) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Pharmerica Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PMC on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NYSE listing.

Key metrics behind Pharmerica Corporation's NYSE-traded stock include a P/E ratio of 41.79 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of PMC on the NYSE.

Price Performance (NYSE: PMC)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateAug 1, 2007
CountryNaN

Frequently Asked Questions